Literature DB >> 9625339

Comparison of the effects of theophylline and caffeine on serum erythropoietin concentration in premature infants.

S Fang1, R A Sherwood, H R Gamsu, J T Marsden, T J Peters, A Greenough.   

Abstract

UNLABELLED: Theophylline administration has been shown to attenuate erythropoietin (EP) production in adults; the effect of caffeine is not known. Our aim was to determine whether caffeine and theophylline had similar effects on EP production in the premature newborn. If caffeine was found to have a greater effect, this would influence prescribing habits. Fifty preterm infants (mean gestational age 28 weeks) who had clinically significant apnoea were randomized to receive theophylline (4 mg/kg then 2 mg/kg twice daily) or caffeine (10 mg/kg then 2.5 mg/kg once daily). The methylxanthines were continued at least until discharge from the NICU and the dosage altered to keep the levels within the therapeutic range. As an assessment of EP production, serum EP concentrations were measured. Blood for EP, haemoglobin, reticulocyte count, theophylline and caffeine levels was obtained prior to treatment and at least during weeks 3 and 7. There was no significant difference in the mean EP level in the two groups taken prior to treatment at a median age of 2 days of life. There were similar falls in haematocrit and haemoglobin in the two groups during the study period compared to pre-treatment values. At that time, however, the median reticulocyte count was higher in the caffeine compared to the theophylline treated infants (P < 0.05). This was associated with a rise compared to baseline (median 10.0-0.2 mU/ml) in the mean EP levels in the caffeine group and a decrease from a median of 10.1 to 8.3 mU/ml in the theophylline group, but the EP levels in the two groups at week 7 did not differ significantly.
CONCLUSION: These results suggest that caffeine does not have a greater impact than theophylline on EP production.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9625339     DOI: 10.1007/s004310050840

Source DB:  PubMed          Journal:  Eur J Pediatr        ISSN: 0340-6199            Impact factor:   3.183


  23 in total

1.  The anemia of prematurity.

Authors:  I SCHULMAN
Journal:  J Pediatr       Date:  1959-05       Impact factor: 4.406

2.  Comparative evaluation of caffeine and theophylline for weaning premature infants from the ventilator.

Authors:  M E Sims; R Rangasamy; S Lee; H Chung; J Cohen; F J Walther
Journal:  Am J Perinatol       Date:  1989-01       Impact factor: 1.862

3.  The effect of adenosine and adenine nucleotides on the cyclic adenosine 3', 5'-phosphate content of guinea pig cerebral cortex slices.

Authors:  A Sattin; T W Rall
Journal:  Mol Pharmacol       Date:  1970-01       Impact factor: 4.436

Review 4.  Effects of drugs on the respiratory control system in the perinatal period and during postnatal development.

Authors:  T Trippenbach
Journal:  Pharmacol Ther       Date:  1983       Impact factor: 12.310

5.  Adverse effects of caffeine and theophylline in the newborn infant.

Authors:  J Howell; M Clozel; J V Aranda
Journal:  Semin Perinatol       Date:  1981-10       Impact factor: 3.300

6.  Erythropoietin (Epo), protein and iron supplementation and the prevention of anaemia of prematurity: effects on serum immunoreactive Epo, growth and protein and iron metabolism.

Authors:  A G Bechensteen; S Halvorsen; P Hågå; P M Cotes; K Liestøl
Journal:  Acta Paediatr       Date:  1996-04       Impact factor: 2.299

7.  Evaluation of the mechanism causing anemia in infants with bronchopulmonary dysplasia.

Authors:  R D Christensen; D D Hunter; H Goodell; G Rothstein
Journal:  J Pediatr       Date:  1992-04       Impact factor: 4.406

Review 8.  The mechanism of action of erythropoietin.

Authors:  J L Spivak
Journal:  Int J Cell Cloning       Date:  1986-05

9.  Cord plasma vasopressin, erythropoietin, and hypoxanthine as indices of asphyxia at birth.

Authors:  V Ruth; F Fyhrquist; G Clemons; K O Raivio
Journal:  Pediatr Res       Date:  1988-10       Impact factor: 3.756

10.  Theophylline metabolism during the first month of life and development.

Authors:  M Bonati; R Latini; G Marra; B M Assael; R Parini
Journal:  Pediatr Res       Date:  1981-04       Impact factor: 3.756

View more
  2 in total

Review 1.  Treatment of apnea of prematurity.

Authors:  Varsha Bhatt-Mehta; Robert E Schumacher
Journal:  Paediatr Drugs       Date:  2003       Impact factor: 3.022

2.  Therapeutic potentials of pentoxifylline for treatment of cardiovascular diseases.

Authors:  Ming Zhang; Yan-Jun Xu; Shushma A Mengi; Amarjit S Arneja; Naranjan S Dhalla
Journal:  Exp Clin Cardiol       Date:  2004
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.